BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23172663)

  • 1. Genome-wide CpG island methylation analyses in non-small cell lung cancer patients.
    Heller G; Babinsky VN; Ziegler B; Weinzierl M; Noll C; Altenberger C; Müllauer L; Dekan G; Grin Y; Lang G; End-Pfützenreuter A; Steiner I; Zehetmayer S; Döme B; Arns BM; Fong KM; Wright CM; Yang IA; Klepetko W; Posch M; Zielinski CC; Zöchbauer-Müller S
    Carcinogenesis; 2013 Mar; 34(3):513-21. PubMed ID: 23172663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation of microRNA-coding genes in non-small-cell lung cancer patients.
    Heller G; Altenberger C; Steiner I; Topakian T; Ziegler B; Tomasich E; Lang G; End-Pfützenreuter A; Zehetmayer S; Döme B; Arns BM; Klepetko W; Zielinski CC; Zöchbauer-Müller S
    J Pathol; 2018 Aug; 245(4):387-398. PubMed ID: 29570800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers.
    Altenberger C; Heller G; Ziegler B; Tomasich E; Marhold M; Topakian T; Müllauer L; Heffeter P; Lang G; End-Pfützenreuter A; Döme B; Arns BM; Klepetko W; Zielinski CC; Zöchbauer-Müller S
    Mol Cancer; 2017 Jan; 16(1):1. PubMed ID: 28093071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation biomarkers for lung cancer.
    Rauch TA; Wang Z; Wu X; Kernstine KH; Riggs AD; Pfeifer GP
    Tumour Biol; 2012 Apr; 33(2):287-96. PubMed ID: 22143938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.
    Wang Y; Zhang D; Zheng W; Luo J; Bai Y; Lu Z
    Cancer; 2008 Mar; 112(6):1325-36. PubMed ID: 18286531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status.
    Tessema M; Yingling CM; Picchi MA; Wu G; Ryba T; Lin Y; Bungum AO; Edell ES; Spira A; Belinsky SA
    Cancer Lett; 2017 Dec; 410():191-200. PubMed ID: 28965852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
    Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD
    Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of tissue-specific differentially methylated genes with differential gene expression in non-small cell lung cancer].
    Yin LG; Zou ZQ; Zhao HY; Zhang CL; Shen JG; Qi L; Qi M; Xue ZQ
    Mol Biol (Mosk); 2014; 48(5):797-804. PubMed ID: 25842865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation transcriptionally regulates the putative tumor cell growth suppressor ZNF677 in non-small cell lung cancers.
    Heller G; Altenberger C; Schmid B; Marhold M; Tomasich E; Ziegler B; Müllauer L; Minichsdorfer C; Lang G; End-Pfützenreuter A; Döme B; Arns BM; Fong KM; Wright CM; Yang IA; Klepetko W; Zielinski CC; Zöchbauer-Müller S
    Oncotarget; 2015 Jan; 6(1):394-408. PubMed ID: 25504438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers.
    Heller G; Weinzierl M; Noll C; Babinsky V; Ziegler B; Altenberger C; Minichsdorfer C; Lang G; Döme B; End-Pfützenreuter A; Arns BM; Grin Y; Klepetko W; Zielinski CC; Zöchbauer-Müller S
    Clin Cancer Res; 2012 Mar; 18(6):1619-29. PubMed ID: 22282464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays.
    Dmitriev AA; Kashuba VI; Haraldson K; Senchenko VN; Pavlova TV; Kudryavtseva AV; Anedchenko EA; Krasnov GS; Pronina IV; Loginov VI; Kondratieva TT; Kazubskaya TP; Braga EA; Yenamandra SP; Ignatjev I; Ernberg I; Klein G; Lerman MI; Zabarovsky ER
    Epigenetics; 2012 May; 7(5):502-13. PubMed ID: 22491060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation discriminators in NSCLC identified by a microarray based approach.
    Field JK; Liloglou T; Warrak S; Burger M; Becker E; Berlin K; Nimmrich I; Maier S
    Int J Oncol; 2005 Jul; 27(1):105-11. PubMed ID: 15942649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay.
    Rauch T; Wang Z; Zhang X; Zhong X; Wu X; Lau SK; Kernstine KH; Riggs AD; Pfeifer GP
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5527-32. PubMed ID: 17369352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation of multiple genes and clinicopathological relationship of non-small cell lung cancers.
    Hanabata T; Tsukuda K; Toyooka S; Yano M; Aoe M; Nagahiro I; Sano Y; Date H; Shimizu N
    Oncol Rep; 2004 Jul; 12(1):177-80. PubMed ID: 15201980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation profiling defines clinically relevant biological subsets of non-small cell lung cancer.
    Walter K; Holcomb T; Januario T; Du P; Evangelista M; Kartha N; Iniguez L; Soriano R; Huw L; Stern H; Modrusan Z; Seshagiri S; Hampton GM; Amler LC; Bourgon R; Yauch RL; Shames DS
    Clin Cancer Res; 2012 Apr; 18(8):2360-73. PubMed ID: 22261801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prognostic DNA methylation signature for stage I non-small-cell lung cancer.
    Sandoval J; Mendez-Gonzalez J; Nadal E; Chen G; Carmona FJ; Sayols S; Moran S; Heyn H; Vizoso M; Gomez A; Sanchez-Cespedes M; Assenov Y; Müller F; Bock C; Taron M; Mora J; Muscarella LA; Liloglou T; Davies M; Pollan M; Pajares MJ; Torre W; Montuenga LM; Brambilla E; Field JK; Roz L; Lo Iacono M; Scagliotti GV; Rosell R; Beer DG; Esteller M
    J Clin Oncol; 2013 Nov; 31(32):4140-7. PubMed ID: 24081945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma.
    Mo ML; Okamoto J; Chen Z; Hirata T; Mikami I; Bosco-Clément G; Li H; Zhou HM; Jablons DM; He B
    PLoS One; 2013; 8(8):e71816. PubMed ID: 23977152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas.
    Heller G; Fong KM; Girard L; Seidl S; End-Pfützenreuter A; Lang G; Gazdar AF; Minna JD; Zielinski CC; Zöchbauer-Müller S
    Oncogene; 2006 Feb; 25(6):959-68. PubMed ID: 16205641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer.
    Rauch TA; Zhong X; Wu X; Wang M; Kernstine KH; Wang Z; Riggs AD; Pfeifer GP
    Proc Natl Acad Sci U S A; 2008 Jan; 105(1):252-7. PubMed ID: 18162535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.